The filing landed on September 9th. Form 1-N, submitted by Coinbase Derivatives, LLC to the SEC. The cover page lists a single product class: single-stock perpetual futures. No press release accompanied the document. No celebratory blog post. Just a regulatory notification that, if approved, will transplant the crypto industry's most leveraged trading instrument into the heart of American equity markets.
This is not an innovation story. This is a jurisdiction story. And the jurisdiction is contested.
The perpetual futures contract β a derivative with no expiry date, anchored to spot prices via periodic funding rate payments β was popularized by BitMEX in 2016. It has since become the dominant instrument in crypto derivatives, accounting for over 70% of global crypto futures volume. The mechanism is elegant: traders speculate on price direction without ever taking delivery of the underlying asset, while the funding rate mechanism β periodic payments between long and short positions β keeps the contract price tethered to the spot market.
Coinbase already operates this product for crypto assets. Their derivatives exchange has processed billions in notional volume since its launch. What the Form 1-N represents is the horizontal expansion of this infrastructure into traditional equities. The same engine, the same risk management systems, the same custody rails β now applied to Apple, Tesla, and Nvidia.
This is the first time a US-regulated entity has formally requested permission to offer single-stock perpetuals on American soil. The offshore market β Bybit, Gate.io, and others β has run these products for years. But those platforms operate outside SEC jurisdiction. Coinbase is voluntarily walking into the regulatory lion's den.
Why would a publicly-traded company, already under SEC scrutiny for its core business, voluntarily expand its regulatory surface area? Because the strategic prize is not the product itself. It is the infrastructure.
The Product Matrix Play
My audit of the filing reveals a coordinated product strategy. Concurrent with the Form 1-N, Coinbase has launched tokenized stock trading, options contracts, and real-world-asset perpetuals indexed to stock market benchmarks. The pre-IPO perpetuals β contracts referencing SpaceX, Anthropic, and OpenAI β have seen trading volume explode from near zero in May to approximately $12 billion.
Let me repeat that figure: $12 billion in notional volume for contracts tied to companies that have no public market, no mandated disclosure, and no standardized price discovery mechanism.
The pre-IPO perpetual is a solution to a problem traditional finance has never solved: how to price and hedge private company equity before an exit event. Venture capital funds hold these positions for 7-10 years with zero liquidity. The secondary markets β Forge Global, EquityZen β provide some exit routes, but they are fragmented, opaque, and illiquid.
Coinbase's perpetuals change this calculus. A trader can take a short position on SpaceX today, without owning a single share or signing a single secondary market agreement. The funding rate mechanism forces convergence between the contract price and whatever the market believes the company is worth. This is price discovery by trading, not by negotiation.
Based on my audit experience with derivatives infrastructure, this is the most significant structural innovation in private market access since the creation of secondary trading platforms. The 10x volume growth in four months is not speculative froth. It is evidence of pent-up demand for a market that simply did not exist before.
The single-stock perpetual filing extends this logic to the public markets. But the regulatory pathway is not clean.
The Jurisdictional Battlefield
The Commodity Futures Trading Commission approved Kalshi's bitcoin perpetual futures in May 2024. The CFTC's position is clear: perpetuals are futures contracts, falling under their jurisdiction. The SEC's position is implied: when the underlying asset is a security, the derivative falls under their jurisdiction. Coinbase has attempted to thread this needle by filing with the SEC while maintaining their CFTC-registered derivatives entity.
CME Group has filed a lawsuit challenging the CFTC's approval of Kalshi's product, arguing that perpetuals are swaps, not futures. If CME prevails, the regulatory framework shifts dramatically. Swaps fall under different rules: mandatory central clearing, different margin requirements, different reporting obligations.
The lawsuit is not about legal purity. It is about market share. CME dominates US derivatives trading. The entry of crypto-native platforms into their territory threatens their franchise. The lawsuit is a commercial strategy dressed in legal garb.
What are the actual legal merits? The distinction between a futures contract and a swap has historically centered on standardized terms, exchange trading, and centralized clearing. Perpetuals are standardized, exchange-traded, and centrally cleared. They function like futures. But they have no delivery date, which CME argues makes them more like swaps.
The legal argument is not frivolous. But the timing β filed immediately after the CFTC approval, occurring simultaneously with Coinbase's SEC registration β suggests competitive motives. CME is not seeking to protect investors. They are seeking to protect their franchise.
The Centralization Risk That No One Discusses
Most analysis of this filing focuses on the regulatory conflict. The overlooked risk is operational.
Coinbase's perpetuals are not settled on-chain. They are settled on Coinbase's centralized matching engine, with Coinbase's risk management systems, under Coinbase's custody model. This is not a smart contract with auditable code. This is a traditional financial product operated by a traditional financial company.
The counterparty risk is not theoretical. If Coinbase faces insolvency β as FTX did β the perpetual positions vanish with the exchange. The contracts are claims on Coinbase, not on the underlying assets.
Consensus is not a feature; it is the foundation. For a decentralized protocol, consensus ensures that no single party can manipulate state. For a centralized exchange, there is no consensus. There is only the exchange's word.
The SEC's disclosure requirements mitigate some of this risk. Coinbase publishes audited financials. They maintain segregated customer accounts. But the legal structure of a perpetual is a contract with the exchange, not a claim on a specific asset.
If I am a trader holding a long position on Tesla perpetuals and Coinbase files for bankruptcy, what is my claim? The contracts are unsecured obligations. I am a general creditor. History is the only reliable audit trail: when FTX collapsed, customer assets were not segregated, and account holders waited months to recover fractions of their holdings.
The irony is that this product β designed to provide leverage for speculation β carries the same counterparty risk profile as the opaque structures that caused the 2008 financial crisis. The opacity is different but the structure is identical: a centralized intermediary standing between the trader and the underlying exposure.
What the Bulls Get Right
The market has reason for optimism. The pre-IPO perpetual volume growth signals genuine demand. The institutional interest in these products is real. And Coinbase's compliance-first approach β voluntary SEC registration, dual regulatory filings, transparent corporate structure β is a template for how traditional finance and crypto can converge.
The CFTC's approval of Kalshi's product, despite the CME lawsuit, indicates regulatory appetite for bringing perpetuals under American oversight. The commissioner's statement that approving bitcoin perpetuals brings "a no-expiry product under US regulation" reflects a coherent policy position. The regulators want to expand their jurisdiction, and the exchanges want to expand their product lines. The alignment is real.
But the market may be underestimating the timeline. The CME lawsuit could take 12-18 months to resolve. SEC review of Form 1-N could take another 6-12 months. The product may not launch until 2026. The market is pricing in approval by the end of 2024. That timeline is aggressive.
The Real Strategic Play
Look beyond the single-stock perpetual. The filing is one component of a broader strategy.
Coinbase is building what appears to be a full-stack capital market infrastructure. The components are:
- Crypto perpetuals β existing, operational
- Single-stock perpetuals β pending SEC approval
- Pre-IPO perpetuals β live, growing 10x in four months
- Tokenized stocks β launched
- Options trading β launched
- RWA perpetuals indexed to stock indices β announced
This is not a product line. This is a market structure. The same infrastructure β matching engine, risk management, custody, settlement β serves all asset classes. The marginal cost of adding a new product is low. The network effect is compounding.
The ledger does not lie, only the operators do. In this case, the operator is Coinbase, and the ledger is their order book. The question is whether the market trusts the operator more than the underlying asset class.
The pre-IPO perpetuals are the most interesting piece. They represent a direct challenge to the traditional private equity model β illiquid, opaque, relationship-driven. If Coinbase's products gain traction, they could create a liquid secondary market for private company equity that has never existed at scale.
The potential impact on the traditional financial system is profound. Pension funds, endowments, and sovereign wealth funds allocate billions to private equity with the understanding that capital is locked for a decade. Perpetuals offer an exit β or at least a hedge β at any time.
This is not a crypto story. This is a financial infrastructure story that happens to be led by a crypto company.
The Accountability Question
What happens when a pre-IPO perpetual on Anthropic β a private company with no obligation to disclose financials β deviates from the funding rate mechanism? Who provides the oracle price? What if the company refuses to participate in the market?
Data does not negotiate; it only confirms. The price discovery mechanism for these products depends on reliable pricing feeds. For public stocks, the data is available from exchanges. For private companies, the data must be sourced from secondary market transactions, funding rounds, and other opaque indicators.
The manipulation surface is non-trivial. A trader with significant capital could distort the funding rate by pushing the contract price away from the true value. Without an authoritative price source, the anchor is weak.
Coinbase has not disclosed its oracle providers. The filing does not specify the pricing mechanism for the pre-IPO products. This is a gap in the information available to the market.
Strategic Positioning
The sideways market has created a vacuum of narratives. The "compliance + convergence" story fills that vacuum. It offers a path forward that does not depend on bitcoin's price action. It is an institutional story, not a retail story.
The market's attention is focused on the CME lawsuit and the SEC review. The real story is the product matrix. The real strategy is the creation of a unified derivatives platform spanning all asset classes. The real risk is not regulatory β it is operational.
Silence in the code is a bug waiting to happen. In this case, the silence is in the legal filings. The absence of details on oracle pricing, liquidation mechanisms, and counterparty risk disclosures is not an oversight. It is a strategic gap β information withheld until the regulatory approval is secured.
The $12 billion in pre-IPO volume tells me the demand is real. The market wants this product. The question is whether the structure β centralized, opaque, regulatory-dependent β can withstand the stress that perpetuals have historically imposed on their operators.
Proof is cheaper than trust, yet still ignored. Coinbase has provided no proof of solvency beyond its audited financials. It has not published stress test results for its derivatives engine. It has not disclosed the counterparty exposure of its pre-IPO book.
The market is pricing in approval, ignoring the timeline, and dismissing the operational risks. The historical pattern is consistent: institutional products launched with insufficient scrutiny, followed by a crisis that regulators and exchanges claim was unforeseeable.
History is the only reliable audit trail. The trail says that perpetuals are high-leverage, high-risk instruments, that centralized exchanges are susceptible to operational failures, and that regulatory approval is not a guarantee of safety.
The filing is a milestone. The product is a test. The outcome is uncertain.
Will the SEC approve? Will the CME lawsuit succeed? Will the pre-IPO market continue to grow?
The answer is not in the filing. The answer is in the market's behavior after the regulatory decisions are made.
We watch. We audit. We wait for the data.